Article
Bosutinib inhibits migration and invasion via ACK1 in KRAS mutant non-small cell lung cancer.
Molecular cancer - 24 Jan 2014
Tan Daniel S W, Haaland Benjamin, Gan Jia Min, Tham Su Chin, Sinha Indrajit, Tan Eng Huat, Lim Kiat Hon, Takano Angela, Krisna Sai Sakktee, Thu Minn Minn Myint, Liew Hoe Peng, Ullrich Axel, Lim Wan-Teck, Chua Boon Tin
Abstract excerpt
The advent of effective targeted therapeutics has led to increasing emphasis on precise biomarkers for accurate patient stratification. Here, we describe the role of ACK1, a non-receptor tyrosine kinase in abrogating migration and invasion in KRAS mutant lung adenocarcinoma. Bosutinib, which inhibits ACK1 at 2.7 nM IC50, was found to inhibit cell migration and invasion but not viability in a panel of non-small...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
